Rakovina Therapeutics Expands Funding for Cancer Research

TipRanksDec 2 18:36 ET

Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update

GlobeNewswireNov 29 20:40 ET

Rakovina Therapeutics Announces Private Placement Offering

GlobeNewswireNov 27 21:33 ET

Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas

GlobeNewswireNov 20 16:30 ET

Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain

GlobeNewswireOct 25 07:30 ET

Rakovina Therapeutics Announces Initial Drug Candidates From Deep Docking AI Molecule Discovery Platform

GlobeNewswireOct 23 07:30 ET